Comparative Outcomes of Basal Insulin and Oral Anti-Diabetic Agent as an Add-On to Dual Therapy in Patients With Type 2 Diabetes Mellitus

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.07.274
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Observational Study of the Use of Insulin Glargine as Basal Therapy in Patients With Type 2 Diabetes Mellitus in Morocco

Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2015English

Erratum To: Evaluation of Add-On Therapy of Sitagliptin in Japanese Patients With Type 2 Diabetes Under Insulin Therapy

Diabetology International
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

BeAM Value: An Indicator of the Need to Initiate and Intensify Prandial Therapy in Patients With Type 2 Diabetes Mellitus Receiving Basal Insulin

BMJ Open Diabetes Research and Care
EndocrinologyMetabolismDiabetes
2016English

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-On Therapy to Metformin in Patients With Uncontrolled Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

A Randomized, Open Label, Comparative Study of Biotin as an Add-On Therapy to Metformin vs Metformin Alone in Newly Diagnosed Type 2 Diabetes Mellitus Patients

IOSR Journal of Dental and Medical Sciences
2016English

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or Prandial Insulin? The APOLLO Trial and Beyond

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2009English

Effect of Switching Basal Insulin Regimen to Degludec on Quality of Life in Japanese Patients With Type 1 and Type 2 Diabetes Mellitus

Journal of Pharmaceutical Health Care and Sciences
2015English

Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-On Therapy in Chinese Patients With Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

U-500 Insulin as a Component of Basal Bolus Insulin Therapy in Type 2 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy